Your browser doesn't support javascript.
loading
Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.
Hamad, Samera H; Montgomery, Stephanie A; Simon, Jeremy M; Bowman, Brittany M; Spainhower, Kyle B; Murphy, Ryan M; Knudsen, Erik S; Fenton, Suzanne E; Randell, Scott H; Holt, Jeremiah R; Hayes, D Neil; Witkiewicz, Agnieszka K; Oliver, Trudy G; Major, M Ben; Weissman, Bernard E.
Afiliación
  • Hamad SH; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Montgomery SA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Simon JM; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Bowman BM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Spainhower KB; Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Murphy RM; UNC Neuroscience Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Knudsen ES; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Fenton SE; Department of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, UT, USA.
  • Randell SH; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Holt JR; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Hayes DN; Division of National Toxicology Program, NIEHS/NIH, Research Triangle Park, NC, USA.
  • Witkiewicz AK; Marsico Lung Institute, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Oliver TG; University of Tennessee Health Science Center for Cancer Research, Department of Medicine, Division of Hematology and Oncology, University of Tennessee, Memphis, TN, USA.
  • Major MB; University of Tennessee Health Science Center for Cancer Research, Department of Medicine, Division of Hematology and Oncology, University of Tennessee, Memphis, TN, USA.
  • Weissman BE; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Oncogene ; 41(39): 4485, 2022 Sep.
Article en En | MEDLINE | ID: mdl-36002660
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Incidence_studies / Risk_factors_studies Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Incidence_studies / Risk_factors_studies Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos